Literature DB >> 15037089

The effects of dopamine agonists and antagonists on the secretory responses in the salivary glands of the locust (Locusta migratoria).

Christopher Keating1, Ian Orchard.   

Abstract

A study has been made on the effect of dopamine on salivary gland secretion rates from isolated locust salivary glands. Application of dopamine induced a concentration-dependent secretion with an IC(50) of approximately 0.3 microM. We investigated the pharmacological profile of this receptor using dopaminergic agonists and antagonists. The effects of dopamine could be mimicked by the selective D1 agonist SKF82958, but not by the D2 agonist TNPA-HCl. The receptor also showed selectively towards certain D1 agonists. SKF82958 was more potent at inducing secretion than SKF81297. We found that dopamine-induced salivary secretions were blocked by the selective D1 antagonist SCH23390, whereas the D2 antagonist sulpiride was relatively ineffective. The cAMP analogue 8-Bromo cAMP also increased secretion rates from isolated salivary glands. These data and the rank order of potency of the agonists and antagonists in this screen suggest that this receptor is a D1-type receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037089     DOI: 10.1016/j.jinsphys.2003.09.005

Source DB:  PubMed          Journal:  J Insect Physiol        ISSN: 0022-1910            Impact factor:   2.354


  3 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Characterization of an invertebrate-type dopamine receptor of the American cockroach, Periplaneta americana.

Authors:  Britta Troppmann; Sabine Balfanz; Christian Krach; Arnd Baumann; Wolfgang Blenau
Journal:  Int J Mol Sci       Date:  2014-01-06       Impact factor: 5.923

3.  Two dopamine receptors play different roles in phase change of the migratory locust.

Authors:  Xiaojiao Guo; Zongyuan Ma; Le Kang
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.